Education
About Us
Working with TipRanks
Follow Us
Mesoblast Limited (MEOBF)
:MEOBF
Total Valuation
Mesoblast Limited has a market cap or net worth of $1.94B. The enterprise value is $2.05B.
Market Cap$1.94B
Enterprise Value$2.05B
Share Statistics
Mesoblast Limited has 1,279,967,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,279,967,200
Owned by Insiders21.39%
Owned by Institutions0.01%
Financial Efficiency
Mesoblast Limited’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -8.48%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-8.48%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee235.59K
Profits Per Employee-1.40M
Employee Count73
Asset Turnover0.02
Inventory Turnover0.23
Valuation Ratios
The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.00
Price to FCF―
Price to Operating Cash Flow-43.48
PEG Ratio―
Income Statement
In the last 12 months, Mesoblast Limited had revenue of 17.20M and earned -102.14M in profits. Earnings per share was -0.09.
Revenue17.20M
Gross Profit12.07M
Operating Income-62.44M
Pretax Income-101.81M
Net Income-102.14M
EBITDA-73.66M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -20.66M and capital expenditures -233.00K, giving a free cash flow of -21.07M billion.
Operating Cash Flow-20.66M
Free Cash Flow-21.07M
Free Cash Flow per Share-0.02
Dividends & Yields
Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change116.42%
50-Day Moving Average1.36
200-Day Moving Average1.55
Relative Strength Index (RSI)42.31
Average Volume (3m)149.00
Important Dates
Mesoblast Limited upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
Mesoblast Limited as a current ratio of 1.99, with Debt / Equity ratio of 21.45%
Current Ratio1.99
Quick Ratio1.77
Debt to Market Cap0.00
Net Debt to EBITDA0.45
Interest Coverage Ratio-2.87
Taxes
In the past 12 months, Mesoblast Limited has paid 330.00K in taxes.
Income Tax330.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Mesoblast Limited EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 0.65.
EV to Sales-1.92
EV to EBITDA0.45
EV to Free Cash Flow0.65
EV to Operating Cash Flow0.66
Balance Sheet
Mesoblast Limited has $38.03M in cash and marketable securities with $126.11M in debt, giving a net cash position of -$88.08M billion.
Cash & Marketable Securities$38.03M
Total Debt$126.11M
Net Cash-$88.08M
Net Cash Per Share-$0.07
Tangible Book Value Per Share$0.00
Margins
Gross margin is -398.00%, with operating margin of -363.08%, and net profit margin of -593.92%.
Gross Margin-398.00%
Operating Margin-363.08%
Pretax Margin-592.00%
Net Profit Margin-593.92%
EBITDA Margin-428.30%
EBIT Margin-465.51%
Analyst Forecast
The average price target for Mesoblast Limited is $2.01, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.01
Price Target Upside38.62% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―